SBIR/STTR Research Award
Biopolymers for Relevant Recombinant Protein Puification
Award amount
$100,000Program and phase
SBIR · Phase IAward year
2004Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- PhaseBio Pharmaceuticals Inc
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- MLJSHGTEWU43
- Solicitation number
- PHS2004-2
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): The long-term objective of this application is to develop a novel protein purification technology, which will eliminate the need for chromatography. This technology, the deltaPhase TM Technology, has greater selectivit
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Safety, tolerability and efficacy of a novel sustained release analog of vasoactive intestinal peptide, PB1046, in patients with pulmonary arterial hypertension
- Safety, tolerability and efficacy of a novel sustained release analog of vasoactive intestinal peptide, PB1046, in patients with pulmonary arterial hypertension
- Smart DeltaPhase Tags for Purification of Recombinant Peptides
- Low Cost Production of Recombinant Proteins
- SBIR Phase I: Use of Phase-Transition Biopolymers as Novel Enzyme Carriers for Biocatalysis
Research funding history
6 SBIR/STTR records share this UEI (2003–2018). Reported award amounts total $3,687,390. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation